Futuristic Safe Injection System 2020

January 1, 2021

Entrepreneurship journey to Safe Injection System

Rescitech Vision Pvt Ltd was founded by a family of five members: Bharati Rathore, Pratibha Rathore, Jai Hind Rathore, Dr. Bhuvan Chandra Rathore, and Late Dr. Neelam Rathore in 2014. The company focuses on inventing and developing cost-effective, safe, and sustainable technology for administering drugs and vaccines. Bharati Rathore spoke to Bio Patrika about their new patented invention “Futuristic Safe Injection System-2020”, now available for licensing and industrial commercialization.

Provide a brief introduction about your education, interests, and entrepreneurship journey.

We, the inventors of Futuristic Safe Injection System-2020, are a family of five:

Bharati Rathore (M.Tech in Cognitive & Neuroscience, University of Rajasthan)
Pratibha Rathore (M.Tech in Medical Nanotechnology, SASTRA University)
Jai Hind Rathore (BS in Mechanical Engineering, Drexel University, USA)
Dr. Bhuvan Chandra Rathore (M.Sc., Ph.D. (Chemistry), LL.B., MIPL, Former Joint Registrar of Trademarks & GI, Ministry of Commerce & Industry, GoI)
Late Dr. Neelam Rathore (Medical Officer, Govt. of Uttar Pradesh)

We founded Rescitech Vision Pvt. Ltd. in 2014 with the mission to create inclusive, green, and sustainable drug/vaccine administration technology to save lives globally without creating a technological divide.

Can you tell us about your new invention?

Syringes are crucial but come with challenges like Needle Stick Injury (NSI), reuse, and sharp waste — all of which spread diseases like HIV/AIDS, Hepatitis B and C. Chronic diseases have increased syringe use, worsening waste issues and healthcare burdens.

Our Make in India invention, Futuristic Safe Injection System-2020, replaces conventional syringes. It includes:

A disposable drug-cartridge with fixed medicament dose packed between a piston and needle.
A reusable injector with a self-retracting mechanism.

Upon injection completion, the needle retracts automatically into the empty cartridge, minimizing NSI and exposure. This system cuts medical waste volume by 70–75% compared to traditional syringe/vial use.

It also lowers cost by eliminating syringe needs and improves efficiency by reducing errors in dosage, contamination risk, and human effort during dose preparation. It saves 10–15% over-filling of medicines and ensures drug efficacy.

Features:

Two reusable injector variants
Multiple drug-cartridge variants
A fluid collector for safe sample collection

The injector includes an LED for better visibility during low light conditions.

Global Patent Recognition:

The European Patent Office and WIPO acknowledged the invention’s economic and safety benefits:

“The technical effect is that the injector is reusable while the only parts to be discarded are the needle hub and the medicament cartridge. A cheaper and environmentally friendlier system is achieved without an increased risk of needle injuries.”

Where did you find the initial spark to develop this innovative technology?

In 2006, we read a WHO report (2002) stating that 70% of injections in the developing world used reused syringes — causing 1.3 million deaths annually and significant spikes in Hepatitis B, C, and HIV/AIDS cases. Unsafe injections were clearly a massive global health issue.

We took this as a mission. While retractable syringes existed, they were expensive. We worked for six years to design safer, affordable alternatives and published five international patent applications in 2014. Eventually, we developed Futuristic Safe Injection System-2020, now patented in the USA, UK, China, South Africa, and pending in India and Japan.

Impact and Vision:

Our invention aims to:

Democratize access to safe drug delivery
Enable mass vaccination
Eradicate unsafe syringe-related disease spread
Achieve SDGs by 2030
Reduce healthcare carbon footprint

Challenges faced:

Our decade-long journey was filled with technical and financial hurdles. We invested everything we had without external funding. The invention was the vision of our late mother, Dr. Neelam Rathore, a dedicated medical officer who inspired and shaped this innovation before her passing during the pandemic.

How do you think your technology will achieve mass vaccination?

With 7.8 billion people needing vaccines during the COVID-19 pandemic, there was an urgent need for billions of safe syringes. Our invention:

Is rapid (1 dose in 30 seconds)
Reduces cost and raw material needs
Cuts hazardous waste
Prevents NSI and reuse
Guarantees fixed dosage with no contamination
Boosts efficiency: 1-2 professionals can deliver 1000 doses/day vs. 5-10 using conventional syringes
Reduces medical manpower need by 75–80%

This ensures last-mile reach and supports global vaccination goals.

YouTube video: https://youtu.be/Fr51vWzLGMA

Recognitions:

EEPC India (2017):
“India’s ‘Futuristic Safe Injection System-2020’ is ready for industrial commercialization.”
WHO’s Global Health Initiative for Needle Safety:
Advocates global shift to smart syringes by 2020.
CAMTech (Massachusetts General Hospital Global Health):
Recognized as an effective solution to reduce NSI risk.

What are your future plans?

To honor Late Dr. Neelam Rathore, we are granting free exclusive licensing in South Africa for five years to support COVID-19 vaccination and healthcare.

We have patents in the top six pharma markets (>70% global share). Given the high demand for safe syringes, we are open to exclusive licensing negotiations globally (excluding South Africa). We invite innovators, entrepreneurs, manufacturers, and market players to help us reach end-users.

Contact:

Rescitech Vision Pvt. Ltd. (OPC)
6H/135, Sector-5 Rajendra Nagar, Sahibabad, Ghaziabad, Uttar Pradesh 201005, India
🌐 Website: https://rescitechvision.com
📧 Email: director.exec@rescitechvision.com